| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |